Gentamicin Induced Nephrotoxicity: The Role of Sex Hormones in Gonadectomized Male and Female Rats

Scientifica

Volumn 2016, Issue , 2016, Pages

  Eshraghi Jazi, Fatemeh ^a   Talebi, Ardeshir ^a   Mirsaeedi, Fatemeh Sadat ^a   Ahmadian, Sarina ^a   Moslemi, Fatemeh ^a   Nematbakhsh, Mehdi ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Isfahan MN Institute of Basic and Applied Sciences Research   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84991488098     PISSN: None     EISSN: 2090908X     Source Type: Journal    
DOI: 10.1155/2016/5025097     Document Type: Article

References (48)

1. R. L. Jao and G. G. Jackson, "Gentamicin sulfate, new antibiotic against gram-negative bacilli. laboratory, pharmacological, and clinical evaluation," The Journal of the American Medical Association, vol. 189, pp. 817-822, 1964.
2. S. H. Powell, W. L. Thompson, M. A. Luthe et al., "Oncedaily vs continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin," The Journal of Infectious Diseases, vol. 147, no. 5, pp. 918-932, 1983.
3. B. H. Ali, "Gentamicin nephrotoxicity in humans and animals: some recent research," General Pharmacology: The Vascular System, vol. 26, no. 7, pp. 1477-1487, 1995.
4. B. H. Ali, A. A. Abdel Gayoum, and A. A. Bashir, "Gentamicin nephrotoxicity in rat: some biochemical correlates," Pharmacology & Toxicology, vol. 70, no. 6, pp. 419-423, 1992.
5. A. Talebi, A. Karimi, K. Ouguerram et al., "Lack of nephroprotective efficacy of Althaea officinalis flower extract against gentamicin renal toxicity in male rats," International Journal of Preventive Medicine, vol. 5, no. 11, pp. 1360-1363, 2014.
6. P. E. Klotman and W. E. Yarger, "Reduction of renal blood flow and proximal bicarbonate reabsorption in rats by gentamicin," Kidney International, vol. 24, no. 5, pp. 638-643, 1983.
7. P. D. Walker, Y. Barri, and S. V. Shah, "Oxidant mechanisms in gentamicin nephrotoxicity," Renal Failure, vol. 21, no. 3-4, pp. 433-442, 2009.
8. M. El Mouedden, G. Laurent, M.-P. Mingeot-Leclercq, H. S. Taper, J. Cumps, and P.M. Tulkens, "Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides," Antimicrobial Agents and Chemotherapy, vol. 44, no. 3, pp. 665-675, 2000.
9. N. Gretz, M. Zeier, S. Geberth, M. Strauch, and E. Ritz, "Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease," American Journal of Kidney Diseases, vol. 14, no. 3, pp. 178-183, 1989.
10. Q. Wei, M.-H. Wang, and Z. Dong, "Differential gender differences in ischemic and nephrotoxic acute renal failure," American Journal of Nephrology, vol. 25, no. 5, pp. 491-499, 2005.
11. F. Eshraghi-Jazi, M. Nematbakhsh, H. Nasri et al., "The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: gender related differences in rat model," Journal of Research in Medical Sciences, vol. 16, no. 11, pp. 1389-1396, 2011.
12. F. Eshraghi-Jazi, M. Nematbakhsh, Z. Pezeshki et al., "Sex differences in protective effect of recombinant human erythropoietin against cisplatin-induced nephrotoxicity in rats," Iranian Journal of Kidney Diseases, vol. 7, no. 5, pp. 383-389, 2013.
13. M. Haghighi, M. Nematbakhsh, A. Talebi et al., "The role of angiotensin II receptor 1 (AT1) blockade in cisplatin-induced nephrotoxicity in rats: gender-related differences," Renal Failure, vol. 34, no. 8, pp. 1046-1051, 2012.
14. S. Jilanchi, M. Nematbakhsh, M. Bahadorani et al., "Vitamine is a nephroprotectant agent in male but not in female in amodel of Cisplatin-induced nephrotoxicity," ISRN Nephrology, vol. 2013, Article ID 280395, 6 pages, 2013.
15. M. Nematbakhsh, S. Ebrahimian, M. Tooyserkani, F. Eshraghi-Jazi, A. Talebi, and F. Ashrafi, "Gender difference in cisplatininduced nephrotoxicity in a rat model: greater intensity of damage in male than female," Nephro-Urology Monthly, vol. 5, no. 3, pp. 818-821, 2013.
16. J.-C. Gautier, T. Gury, M. Guffroy et al., "Comparison between male and female sprague-dawley rats in the response of urinary biomarkers to injury induced by gentamicin," Toxicologic Pathology, vol. 42, no. 7, pp. 1105-1116, 2014.
17. M. Nematbakhsh, Z. Pezeshki, F. Eshraghi-Jazi et al., "Vitamin E, vitamin C, or losartan is not nephroprotectant against cisplatin-induced nephrotoxicity in presence of estrogen in ovariectomized rat model," International Journal of Nephrology, vol. 2012, Article ID284896, 10 pages, 2012.
18. Z. Pezeshki, M. Nematbakhsh, S. Mazaheri et al., "Estrogen abolishes protective effect of erythropoietin against cisplatininduced nephrotoxicity in ovariectomized rats," ISRN Oncology, vol. 2012, Article ID890310, 7 pages, 2012.
19. Z. Pezeshki, M. Nematbakhsh, H. Nasri et al., "Evidence against protective role of sex hormone estrogen in cisplatin-induced nephrotoxicity in ovarectomized rat model," Toxicology International, vol. 20, no. 1, pp. 43-47, 2013.
20. B. Rostami, M. Nematbakhsh, Z. Pezeshki et al., "Effect of testosterone on Cisplatin-induced nephrotoxicity in surgically castrated rats," Nephro-Urology Monthly, vol. 6, no. 5, Article ID e21546, 2014.
21. B. H. Ali, T. H. B. Ismail, and A. A. Bashir, "Sex difference in the susceptibility of rats to gentamicin nephrotoxicity: influence of gonadectomy and hormonal replacement therapy," Indian Journal of Pharmacology, vol. 33, no. 5, pp. 369-373, 2001.
22. W. M. Bennett, R. A. Parker, W. C. Elliott, D. N. Gilbert, and D. C. Houghton, "Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity," Journal of Infectious Diseases, vol. 145, no. 3, pp. 370-373, 1982.
23. J. C. Carraro-Eduardo, A. V. Oliveira, M. E. Carrapatoso, and J. F. R. Ornellas, "Effect of sex hormones on gentamicininduced nephrotoxicity in rats," Brazilian Journal of Medical and Biological Research, vol. 26, no. 6, pp. 653-662, 1993.
24. M. Grott, S. Karakaya, F. Mayer et al., "Progesterone and estrogen prevent cisplatin-induced apoptosis of lung cancer cells," Anticancer Research, vol. 33, no. 3, pp. 791-800, 2013.
25. B. Antus, P. Hamar, G. Kokeny et al., "Estradiol is nephroprotective in the rat remnant kidney," Nephrology Dialysis Transplantation, vol. 18, no. 1, pp. 54-61, 2003.
26. F. Sadeghi, M. Nematbakhsh, A. Noori-Diziche et al., "Protective effect of pomegranate flower extract against gentamicininduced renal toxicity in male rats," Journal of Renal Injury Prevention, vol. 4, no. 2, pp. 45-50, 2015.
27. C. Acharya, H. Thakar, and S. K. Vajpeyee, "A study of oxidative stress in gentamicin induced nephrotoxicity and effect of antioxidant vitamin C in wistar rats," National Journal of Physiology, Pharmacy and Pharmacology, vol. 3, no. 1, pp. 14-20, 2013.
28. M. Tavafi, H. Ahmadvand, and P. Toolabi, "Inhibitory effect of olive leaf extract on gentamicin-induced nephrotoxicity in rats," Iranian Journal of Kidney Diseases, vol. 6, no. 1, pp. 25-32, 2012.
29. M. Fartashvand, G. Mousavi, and Y. Hajisadeghi, "Gentamicininduced nephrotoxicity in adult sheep," Advances in Bioresearch, vol. 3, no. 4, 2012.
30. H. F. Hasan, A. M. Hamzah, and Z. R. Zghair, "Study the comparative effect between Cyperus esculentus seeds extract and gentamicin on induced endometritis in mice," Journal of Pharmacy and Clinical Sciences, vol. 7, pp. 40-47, 2013.
31. A. Soljancic, A. L. Ruiz, K. Chandrashekar et al., "Protective role of testosterone in ischemia-reperfusion-induced acute kidney injury," The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 304, no. 11, pp. R951-958, 2013.
32. M. Ayaz, M. Akand, Y. Kucukbagriacik, and D. Dursunoglu, "The effects of estradiol on cardiac muscle electrophysiology in orchiectomized ratmodel: a newinsight to side effects caused by castration," European Review for Medical and Pharmacological Sciences, vol. 19, no. 15, pp. 2866-2874, 2015.
33. A. Iran-Nejad, M. Nematbakhsh, F. Eshraghi-Jazi, and A. Talebi, "Preventive role of estradiol on kidney injury induced by renal ischemia-reperfusion in male and female rats," International Journal of Preventive Medicine, vol. 6, article 22, 2015.
34. T. I. S. Hwang, T.-L. Liao, J.-F. Lin et al., "Low-dose testosterone treatment decreases oxidative damage in TM3 Leydig cells," Asian Journal of Andrology, vol. 13, no. 3, pp. 432-437, 2011.
35. L. Zhang, S. Wu, Y. Ruan, L. Hong, X. Xing, and W. Lai, "Testosterone suppresses oxidative stress via androgen receptorindependent pathway in murine cardiomyocytes," Molecular Medicine Reports, vol. 4, no. 6, pp. 1183-1188, 2011.
36. A. Dixon and C. Maric, "17β-Estradiol attenuates diabetic kidney disease by regulating extracellularmatrix and transforming growth factor-β protein expression and signaling," American Journal of Physiology-Renal Physiology, vol. 293, no. 5, pp. F1678-F1690, 2007.
37. H. Hanke, S. Hanke, B. Bruck et al., "Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis," Atherosclerosis, vol. 121, no. 1, pp. 129-138, 1996.
38. X. Meng, X. Dai, T. Liao et al., "Dose-dependent toxic effects of high-dose estrogen on renal and cardiac injury in surgically postmenopausal mice," Life Sciences, vol. 88, no. 3-4, pp. 178-186, 2011.
39. M. Ghasemi, M. Nematbakhsh, Z. Pezeshki, N. Soltani, M. Moeini, and A. Talebi, "Nephroprotective effect of estrogen and progesterone combination on cisplatin-induced nephrotoxicity in ovariectomized female rats," Indian Journal of Nephrology, In press.
40. N. Santanam, R. Shern-Brewer, R. McClatchey et al., "Estradiol as an antioxidant: incompatible with its physiological concentrations and function," Journal of Lipid Research, vol. 39, no. 11, pp. 2111-2118, 1998.
41. R. L. Roof, S. W. Hoffman, and D. G. Stein, "Progesterone protects against lipid peroxidation following traumatic brain injury in rats," Molecular and Chemical Neuropathology, vol. 31, no. 1, pp. 1-11, 1997.
42. T. Delibasi, C. Kockar, A. Celik, and O. Kockar, "Antioxidant effects of hormone replacement therapy in postmenopausal women," Swiss Medical Weekly, vol. 136, no. 31-32, pp. 510-514, 2006.
43. F. Ghadirian, M. Nematbakhsh, S. Roozbehani et al., "Nonprotective role of losartan in cisplatin-induced nephrotoxicity in ovariectomized rat model treated with estradiol," Journal of Pharmaceutical Negative Results, vol. 6, no. 1, pp. 2-6, 2015.
44. S. Brody and N. Wiqvist, "Ovarian hormones and uterine growth: effects of estradiol, progesterone and relaxin on cell growth and cell division in the rat uterus," Endocrinology, vol. 68, no. 6, pp. 971-977, 1961.
45. L. Chmouliovsky, F. Habicht, R.W. James, T. Lehmann, A. Campana, and A. Golay, "Beneficial effect of hormone replacement therapy onweight loss in obese menopausal women," Maturitas, vol. 32, no. 3, pp. 147-153, 1999.
46. Z. F. Dewan, I. D. Morris, and R. G. Lendon, "Administration of exogenous testosterone in the adult rat and its effects on reproductive organs, sex hormones and body-weight," Bangladesh Medical Research Council Bulletin, vol. 26, no. 2, pp. 48-55, 2000.
47. C. D. Kochakian and J. A. Webster, "Effect of testosterone propionate on the appetite, body weight and composition of the normal rat," Endocrinology, vol. 63, no. 6, pp. 737-742, 1958.
48. P. U. Dubuc, "Effects of estrogen on food intake, body weight, and temperature ofmale and female obesemice," Proceedings of the Society for Experimental Biology and Medicine, vol. 180, no. 3, pp. 468-473, 1985.